The molecular basis of Tay-Sachs disease: Mutation identification and diagnosis
- 1 October 1990
- journal article
- other
- Published by Elsevier in Clinical Biochemistry
- Vol. 23 (5) , 409-415
- https://doi.org/10.1016/0009-9120(90)90153-l
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Isolation of a cDNA encoding the human GM2 activator proteinFEBS Letters, 1989
- A Point Mutation in the Coding Sequence of the β‐Hexosaminidase α Gene Results in Defective Processing of the Enzyme Protein in an Unusual GM2‐Gangliosidosis VariantJournal of Neurochemistry, 1988
- Identification of an altered splice site in Ashkenazi Tay-Sachs diseaseNature, 1988
- A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs diseaseBiochemical and Biophysical Research Communications, 1988
- Different Mutations in Ashkenazi Jewish and Non-Jewish French Canadians with Tay-Sachs DiseaseScience, 1986
- Mapping of the gene coding for the human GM2 activator protein to chromosome 5Annals of Human Genetics, 1985
- Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological DisordersDevelopmental Neuroscience, 1983
- Expression of Hexosaminidase Isoenzymes in Childhood LeukemiaNew England Journal of Medicine, 1978
- Assignment of the human gene for hexosaminidase B to chromosome 5Experimental Cell Research, 1975
- Variation of β‐N‐acetylhexosaminidase‐pattern in Tay‐Sachs diseaseFEBS Letters, 1969